4SC-205

Eg5 kinesin-spindle inhibitor · 4SC AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4SC-205, covering 2015-04-13 to 2015-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies [Phase 1]

See pricing